First Time Loading...

Vertex Pharmaceuticals Inc
NASDAQ:VRTX

Watchlist Manager
Vertex Pharmaceuticals Inc Logo
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Watchlist
Price: 401.08 USD 0.23% Market Closed
Updated: May 6, 2024
Section:
 

Relative Value

The Relative Value of one VRTX stock under the Base Case scenario is 247.36 USD. Compared to the current market price of 401.08 USD, Vertex Pharmaceuticals Inc is Overvalued by 38%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VRTX Relative Value
Base Case
247.36 USD
Overvaluation 38%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

10.5
P/S
P/S
Price to Sales
10.5
vs History
38
vs Industry
46
Median 3Y
8.8
Median 5Y
9.5
Industry
8.3
Forward
9.5
More Details
28.6
P/E
P/E
Price to Earnings
28.6
vs History
22
vs Industry
6
Median 3Y
25.6
Median 5Y
25.6
Industry
26.8
Forward
23.4
More Details
29.2
P/OCF
P/OCF
Price to OCF
29.2
vs History
30
vs Industry
6
Median 3Y
21.9
Median 5Y
23.6
Industry
23.3
More Details
32.3
P/FCFE
P/FCFE
Price to FCFE
32.3
vs History
30
vs Industry
5
Median 3Y
23.9
Median 5Y
26.7
Industry
21.4
More Details
5.9
P/B
P/B
Price to Book Value
5.9
vs History
65
vs Industry
15
Median 3Y
5.9
Median 5Y
6.2
Industry
2.6
More Details
9.3
EV/S
EV/S
Enterprise Value to Sales
9.3
vs History
38
vs Industry
40
Median 3Y
7.8
Median 5Y
8.4
Industry
7.5
Forward
8.4
More Details
10.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.7
vs History
38
vs Industry
39
Median 3Y
8.9
Median 5Y
9.6
Industry
9.2
More Details
22.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
22.8
vs History
38
vs Industry
6
Median 3Y
18.8
Median 5Y
19.4
Industry
4.5
Forward
17.8
More Details
23.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
23.9
vs History
38
vs Industry
6
Median 3Y
19.5
Median 5Y
20.4
Industry
4.4
Forward
18.6
More Details
25.9
EV/OCF
EV/OCF
Enterprise Value to OCF
25.9
vs History
33
vs Industry
6
Median 3Y
19.2
Median 5Y
21
Industry
5.6
More Details
28
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
28
vs History
30
vs Industry
6
Median 3Y
20.3
Median 5Y
23
Industry
3.4
More Details
12.6
EV/IC
EV/IC
Enterprise Value to IC
12.6
vs History
30
vs Industry
19
Median 3Y
9.6
Median 5Y
10.6
Industry
5
More Details

Multiples Across Competitors

VRTX Competitors Multiples
Vertex Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.4B USD 10.5 28.6 22.8 23.9
US
Abbvie Inc
NYSE:ABBV
289.2B USD 5.3 60 13 19.9
US
Amgen Inc
NASDAQ:AMGN
166.7B USD 5.9 24.8 17.9 26.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
104.7B USD 8 26.5 17.8 19.6
AU
CSL Ltd
ASX:CSL
133.2B AUD 6.2 35.7 21.6 26.8
US
Gilead Sciences Inc
NASDAQ:GILD
80.7B USD 2.9 166.8 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
47.8B USD 7 -10.1 -11 -9.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.7B USD 3.3 27.1 13.9 17.4
KR
Celltrion Inc
KRX:068270
39.2T KRW 18 73.1 44.7 61.6
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD 7.3 60.8 27.9 47

See Also

Summary
VRTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
VRTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VRTX stock valuation using valuation multiples.
Wall Street Estimates
VRTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VRTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.